Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antipsychotics Commonly Used Off-Label By Dementia Patients, AHRQ Finds

Executive Summary

About 25 percent of people with dementia living in either a community setting or long-term care facility receive cholinesterase inhibitors, a government-funded study found

You may also be interested in...



Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs

Omnicare's settlement with the Department of Justice to resolve kickback allegations was remarkable for the breadth and complexity of the government's case. But it also cast attention on a particular segment of the pharmaceutical market: nursing homes

Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs

Omnicare's settlement with the Department of Justice to resolve kickback allegations was remarkable for the breadth and complexity of the government's case. But it also cast attention on a particular segment of the pharmaceutical market: nursing homes

Boxed Warning For Antipsychotics First Public Use Of FDA Labeling Authority

FDA put its new labeling authority under the FDA Amendments Act on public display June 16 by directing makers of conventional antipsychotics to add to their drugs' prescribing information a boxed warning about use in elderly patients with dementia

Related Content

UsernamePublicRestriction

Register

PS049687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel